Open Innovation Publications & Expert Interviews Archives - Page 3 of 23 - Biowebspin | Biowebspin
Logo Biowebspin
#1 source of information and interviews about academia-industry partneringFollow the latest expert interviews and publications about academia-industry partnering,
technology transfer and licensing in Life Sciences

Open Innovation Publications & Expert Interviews

Women Business Leaders in Biotech and Hi-Tech, and Related Industry Cluster Factors

Women Business Leaders in Biotech and Hi-Tech, and Related Industry Cluster Factors

  Biowebspin, October 10th, 2016 Women Business Leaders in Biotech and Hi-Tech, and Related Industry Cluster Factors by Jessica White, San Jose State University, 2016 Women entrepreneurs are on the rise and their numbers have grown at one and a half times the rate of small enterprises generally over the last 15 years. In spite of this, women are underrepresented in the fields of science, technolog... »

Fund my treatment!: A call for ethics-focused social science research into the use of crowdfunding for medical care

Fund my treatment!: A call for ethics-focused social science research into the use of crowdfunding for medical care

  Biowebspin, October 03th, 2016 Fund my treatment!: A call for ethics-focused social science research into the use of crowdfunding for medical care by Donrich W. Jordaan, in Soc Sci Med., 2016 Crowdfunding involves raising money from large groups of individuals, often through the use of websites dedicated to this purpose. Crowdfunding campaigns aimed at raising money to pay for expenses related t... »

Selling science 2.0: What scientific projects receive crowdfunding online?

Selling science 2.0: What scientific projects receive crowdfunding online?

  Biowebspin, September 26th, 2016 Selling science 2.0: What scientific projects receive crowdfunding online? by Mike S. Schäfer, Julia Metag, Jessica Feustle and Livia Herzog in Public understanding of science, 2016 Crowdfunding has emerged as an additional source for financing research in recent years. The study at hand identifies and tests explanatory factors influencing the success of scienti... »

Frugal innovation, sustainable innovation, reverse innovation: why do they look alike? Why are they different?

Frugal innovation, sustainable innovation, reverse innovation: why do they look alike? Why are they different?

  Biowebspin, September 21th, 2016 Frugal innovation, sustainable innovation, reverse innovation: why do they look alike? Why are they different? by Christian Le Bas in Journal of Innovation Economics & Management, 2016 This paper is about three types of innovation that are emerging in the landscape of innovation studies: frugal innovation (FI), sustainable innovation (SI) and reverse innovati... »

Leveraging Industry-Academia Collaborations in Adaptive Biomedical Innovation

Leveraging Industry-Academia Collaborations in Adaptive Biomedical Innovation

Biowebspin, September 19th, 2016 Leveraging Industry-Academia Collaborations in Adaptive Biomedical Innovation by S. R. Stewart, P. W. Barone, A. Bellisario, C. L. Cooney, P. A. Sharp, A. J. Sinskey, S. Natesan, S. L. Springs, in Clinical Pharmacology & Therapeutics, 2016 Despite the rapid pace of biomedical innovation, R&D productivity in the pharmaceutical industry has not improved broad... »

Using transaction cost economics to explain open innovation in start-ups

Using transaction cost economics to explain open innovation in start-ups

  Biowebspin, September 12th, 2016 Using transaction cost economics to explain open innovation in start-ups by Ching-Tang Hsieh, Hao-Chen Huang, Wei-Long Lee, in Management Decision, 2016 Purpose The basic concept of transaction cost theory is that firms like to conduct transactions in a channel with lower transaction costs. Therefore, this work uses the transaction cost perspective to identify wh... »

Implicit patent alliance acquiring the appropriability of innovation

Implicit patent alliance acquiring the appropriability of innovation

  Biowebspin, September 5th, 2016 Implicit patent alliance acquiring the appropriability of innovation by Yoshimasa Goto, Kiminori Gemba, in International Journal of Technology Management, 2016 This paper proposes an innovation management scheme, an 'implicit patent alliance', to support the appropriability of innovation. A case study on inkjet printer companies is conducted to examine its potenti... »

From open innovation to enginomics: Paradigm shifts

From open innovation to enginomics: Paradigm shifts

  Biowebspin, September 1st, 2016 From open innovation to enginomics: Paradigm shifts by Sam Saguy, Petros S. Taoukis, in Trends in Food Science & Technology, 2016 Food engineering is at a crossroads. Inertia, combined with diminishing research funding, declining new academic positions, combined with disruptive and emerging competitive adjacent domains have a heavy toll on the field and its at... »

How does venture capital operate in medical innovation?

How does venture capital operate in medical innovation?

  Biowebspin, August 30th, 2016 How does venture capital operate in medical innovation? by Lehoux P, Miller FA, Daudelin G in BMJ Innovations, 2016 While health policy scholars wish to encourage the creation of technologies that bring more value to healthcare, they may not fully understand the mandate of venture capitalists and how they operate. This paper aims to clarify how venture capital opera... »

Donata Mauricaité is speaking about Life Sciences Baltics – september 14-15, 2016, vilnius, lithuania

Donata Mauricaité is speaking about Life Sciences Baltics – september 14-15, 2016, vilnius, lithuania

  »

Page 3 of 2312345»